However, an increasing number of studies are looking to assess the value of ‘alternative indicators’ (serology and PCR for trachoma surveillance), as it has been suggested that other factors may cause TF-like symptoms making it difficult to ascertain at low TF prevalence levels whether what is being observed is truly TF. The gene discussed is TF; the disease is inclusion conjunctivitis.